Invesco’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,895,594
Closed -$983M 3788
2019
Q3
$983M Buy
9,895,594
+158,823
+2% +$15.1M 0.26% 69
2019
Q2
$900M Buy
9,736,771
+16,421
+0.2% +$1.56M 0.23% 80
2019
Q1
$917M Sell
9,720,350
-2,988,503
-24% -$261M 0.31% 48
2018
Q4
$815M Buy
12,708,853
+538,324
+4% +$39.7M 0.31% 59
2018
Q3
$1.09B Buy
12,170,529
+279,315
+2% +$24.7M 0.34% 49
2018
Q2
$944M Buy
11,891,214
+1,256,171
+12% +$104M 0.31% 57
2018
Q1
$949M Sell
10,635,043
-1,945,584
-15% -$187M 0.35% 50
2017
Q4
$1.31B Buy
12,580,627
+349,367
+3% +$39.4M 0.47% 21
2017
Q3
$1.78B Sell
12,231,260
-222,115
-2% -$30.3M 0.66% 15
2017
Q2
$1.62B Sell
12,453,375
-87,627
-0.7% -$10.7M 0.5% 27
2017
Q1
$1.56B Sell
12,541,002
-45,807
-0.4% -$5.48M 0.51% 27
2016
Q4
$1.46B Buy
12,586,809
+54,021
+0.4% +$6.02M 0.49% 29
2016
Q3
$1.31B Buy
12,532,788
+575,199
+5% +$62.3M 0.45% 33
2016
Q2
$1.18B Buy
11,957,589
+402,844
+3% +$41.7M 0.43% 35
2016
Q1
$1.16B Sell
11,554,745
-1,234,053
-10% -$127M 0.47% 31
2015
Q4
$1.53B Sell
12,788,798
-157,546
-1% -$18.2M 0.61% 20
2015
Q3
$1.4B Sell
12,946,344
-923,899
-7% -$115M 0.59% 21
2015
Q2
$1.61B Sell
13,870,243
-125,351
-0.9% -$14.3M 0.63% 17
2015
Q1
$1.61B Sell
13,995,594
-947,977
-6% -$113M 0.62% 17
2014
Q4
$1.67B Sell
14,943,571
-173,923
-1% -$18.3M 0.65% 17
2014
Q3
$1.43B Sell
15,117,494
-1,066,444
-7% -$96.2M 0.57% 20
2014
Q2
$1.39B Buy
16,183,938
+1,419,956
+10% +$108M 0.55% 22
2014
Q1
$1.03B Sell
14,763,982
-2,458,740
-14% -$195M 0.42% 30
2013
Q4
$1.46B Sell
17,222,722
-35,044
-0.2% -$2.77M 0.58% 22
2013
Q3
$1.33B Buy
17,257,766
+1,480,958
+9% +$104M 0.58% 23
2013
Q2
$923M Buy
+15,776,808
New +$949M 0.43% 32

Other funds holding CELG

Invesco's CELG Position: Q4 2019 in Review

Invesco sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,895,594 shares — an estimated $983M sold.

Invesco first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.78B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Invesco reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Invesco sold 9,895,594 Celgene Corp shares in Q4 2019, an estimated $983M.
  • Invesco first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Invesco's Celgene Corp position peaked at $1.78B in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Invesco's 13F filing for Q4 2019, filed 14 Feb 2020.